Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Avatrombopag is a drug used to treat thrombocytopenia, but its side effects are of great concern.Are the side effects of avatrombopag seriousWhether the side effects of avatrombopa···【more】
Article source：Captain MedicineRelease date：2025-02-05Recommended：306
Avatrombopag is a drug used to treat thrombocytopenia, but its use may be accompanied by some side effects.What are the side effects of avatrombopag?Avatrombopag may cause some adv···【more】
Article source：Captain MedicineRelease date：2025-02-05Recommended：286
Avatrombopag is a novel thrombopoietin receptor agonist, and its therapeutic effect has attracted much attention.Does avatrombopag workAvatrombopag has demonstrated significant eff···【more】
Article source：Captain MedicineRelease date：2025-01-22Recommended：316
Avatrombopag is a novel thrombopoietin receptor agonist that has attracted much attention in clinical practice.Is avatrombopag treatment effective?Avatrombopag has shown unique eff···【more】
Article source：Captain MedicineRelease date：2025-01-22Recommended：310
Avatrombopag is a new oral thrombopoietin receptor agonist, which has been widely used in clinical practice to increase platelet count, and its therapeutic effect has attracted muc···【more】
Article source：Captain MedicineRelease date：2025-01-21Recommended：305
Avatrombopag is a novel thrombopoietin receptor agonist, which has attracted much attention in clinical application.What is the dosage of avatrombopagKnowing the correct dosage of ···【more】
Article source：Captain MedicineRelease date：2025-01-21Recommended：257
Avatrombopag is a new type of drug, and its correct use is critical to the patient's treatment outcome.How to use avatrombopagKnowing the correct way to use avatrombopag can he···【more】
Article source：Captain MedicineRelease date：2025-01-20Recommended：221
Avatrombopag is a novel oral thrombopoietin receptor agonist, and its dosage has attracted much attention.What is the recommended dosage of avatrombopag?Knowing the correct dosage ···【more】
Article source：Captain MedicineRelease date：2025-01-20Recommended：300
Avatrombopag is a novel oral thrombopoietin receptor agonist that has demonstrated significant efficacy in clinical application and provides a new treatment option for specific pat···【more】
Article source：Captain MedicineRelease date：2025-01-17Recommended：328
Avatrombopag is an innovative drug that plays an important role in clinical treatment, especially for patients with specific diseases.What diseases is avatrombopag suitable for?Ava···【more】
Article source：Captain MedicineRelease date：2025-01-17Recommended：315
Avatrombopag is a novel drug that has demonstrated unique therapeutic potential in specific medical areas.What are the indications for avatrombopagExploring the indications for ava···【more】
Article source：Captain MedicineRelease date：2025-01-17Recommended：287
Avatrombopag is a novel drug that has demonstrated unique therapeutic potential in specific medical areas.What are the indications for avatrombopagExploring the indications for ava···【more】
Article source：Captain MedicineRelease date：2025-01-16Recommended：374
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4472025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：6362024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：902026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：4142025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：4332025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：4182025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4742025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3852025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
